Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H F Dullens

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Immunology Today|February 1, 1992
T cells and tumorsR A Maas, H F Dullens, W Den Otter
European Journal of Cancer|January 1, 1974
Immunotherapy with allogeneic hyperimmune peritoneal cells in a murine lymphoma systemH F Dullens, F J Kingma, W den Otter
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Interleukin-2 in cancer treatment: disappointing or (still) promising? A reviewR A Maas, H F Dullens, W Den Otter
In Vivo (Athens, Greece)|November 1, 1991
Mechanisms of tumor regression induced by low doses of interleukin-2R A Maas, H F Dullens, W Den Otter
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipientsW Den Otter, J W De Groot, H F Dullens
Immunology Today|October 8, 2014
Sponsorship of scientific workH F Dullens, R A De Weger, W Den Otter
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Macrophages and antitumor reactionsW Den Otter, H F Dullens, R A De Weger
Immunological Reviews|January 1, 1982
Eradication of murine lymphoma and melanoma cells by chlorambucil-antibody complexesR A De Weger, H F Dullens, W Den Otter
Anticancer Research|January 1, 1996
The glycosylation profile of interleukin-2 activated human lymphocytes correlates to their anti-tumor activityH Voshol, H F Dullens, W Den Otter, et al.
Journal of Immunological Methods|September 27, 1993
Human natural killer cells: a convenient purification procedure and the influence of cryopreservation on cytotoxic activityH Voshol, H F Dullens, W Den Otter, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Immunology Today|February 1, 1992
T cells and tumorsR A Maas, H F Dullens, W Den Otter
European Journal of Cancer|January 1, 1974
Immunotherapy with allogeneic hyperimmune peritoneal cells in a murine lymphoma systemH F Dullens, F J Kingma, W den Otter
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Interleukin-2 in cancer treatment: disappointing or (still) promising? A reviewR A Maas, H F Dullens, W Den Otter
In Vivo (Athens, Greece)|November 1, 1991
Mechanisms of tumor regression induced by low doses of interleukin-2R A Maas, H F Dullens, W Den Otter
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipientsW Den Otter, J W De Groot, H F Dullens
Immunology Today|October 8, 2014
Sponsorship of scientific workH F Dullens, R A De Weger, W Den Otter
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Macrophages and antitumor reactionsW Den Otter, H F Dullens, R A De Weger
Immunological Reviews|January 1, 1982
Eradication of murine lymphoma and melanoma cells by chlorambucil-antibody complexesR A De Weger, H F Dullens, W Den Otter
Anticancer Research|January 1, 1996
The glycosylation profile of interleukin-2 activated human lymphocytes correlates to their anti-tumor activityH Voshol, H F Dullens, W Den Otter, et al.
Journal of Immunological Methods|September 27, 1993
Human natural killer cells: a convenient purification procedure and the influence of cryopreservation on cytotoxic activityH Voshol, H F Dullens, W Den Otter, et al.
Pageof 7